docetaxel anhydrous has been researched along with beta-elemene in 2 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (beta-elemene) | Trials (beta-elemene) | Recent Studies (post-2010) (beta-elemene) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 258 | 1 | 211 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cuff, CF; Li, JM; Li, QQ; Reed, E; Zhao, J; Zou, B | 1 |
Tang, JH; Yao, YF; Zhang, HD; Zhang, J; Zhao, JH; Zhong, SL | 1 |
2 other study(ies) available for docetaxel anhydrous and beta-elemene
Article | Year |
---|---|
β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Synergism; Female; Humans; Ovarian Neoplasms; Paclitaxel; Sesquiterpenes; Taxoids | 2013 |
β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Coculture Techniques; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Exosomes; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Luciferases; MCF-7 Cells; Oligonucleotide Array Sequence Analysis; PTEN Phosphohydrolase; Sesquiterpenes; Taxoids | 2015 |